Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine

This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting with severe left ventricular dysfunction and hemodynamic instability. The two cases were managed differently. The first required mechanical ventilation and was resistant to conventional antiarrhythmic drugs. After the initiation of enteral ivabradine (0.15mg/kg) the heart rate slowed with significant improvement in hemodynamics, peripheral perfusion and sinus rhythm was restored after 12 hours. Ivabradine was continued and the patient was discharged home after 10 days of hospitalization. The second case was managed by early initiation of ivabradine and resulted in restoration of sinus rhythm within 4 hours, thus avoiding trials of conventional anti-arrhythmic drugs with unstable hemodynamic profile. The infant was discharged after 5 days of hospitalization on ivabradine..

[1]  M. Melter,et al.  Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report , 2020, Frontiers in Pediatrics.

[2]  Mitchell I. Cohen,et al.  Ivabradine as a stabilising anti-arrhythmic agent for multifocal atrial tachycardia , 2020, Cardiology in the Young.

[3]  D. Padmanabhan,et al.  Clinical and Electrophysiological Correlates of Incessant Ivabradine-Sensitive Atrial Tachycardia. , 2019, Circulation. Arrhythmia and electrophysiology.

[4]  V. Vetter,et al.  Ivabradine for treatment of tachyarrhythmias in children and young adults , 2019, HeartRhythm case reports.

[5]  E. Ozturk,et al.  Ivabradine is an effective antiarrhythmic therapy for congenital junctional ectopic tachycardia‐induced cardiomyopathy during infancy: Case studies , 2018, Pacing and clinical electrophysiology : PACE.

[6]  P. Kantor,et al.  Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure. , 2017, Journal of the American College of Cardiology.

[7]  K. Klingel,et al.  Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. , 2017, Journal of the American College of Cardiology.

[8]  H. Ge,et al.  Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children , 2017, Pediatric Cardiology.

[9]  S. Etheridge,et al.  Current Management of Focal Atrial Tachycardia in Children: A Multicenter Experience , 2014, Circulation. Arrhythmia and electrophysiology.

[10]  R. Mandapati,et al.  Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy. , 2014, Heart rhythm.

[11]  S. Bohora,et al.  Reversal of Tachycardiomyopathy Due to Left Atrial Tachycardia by Ivabradine , 2011, Journal of cardiovascular electrophysiology.

[12]  R. Friedman,et al.  Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children < 3 or > or =3 years of age. , 2004, Journal of the American College of Cardiology.

[13]  S. Kothari,et al.  Management of cardiomyopathy resulting from incessant supraventricular tachycardia in infants and children. , 2002, Indian heart journal.

[14]  F. Marchlinski,et al.  Adenosine as an antiarrhythmic agent. , 1997, The American journal of cardiology.

[15]  J. Strasburger,et al.  Natural history and management strategies of automatic atrial tachycardia in children. , 1995, The American journal of cardiology.

[16]  P. Gillette,et al.  Radiofrequency catheter ablation of incessant, medically resistant supraventricular tachycardia in infants and small children. , 1992, Journal of the American College of Cardiology.

[17]  J. Kirsh,et al.  Cardiovascular Collapse with Intravenous Amiodarone in Children: A Multi-Center Retrospective Cohort Study , 2019, Pediatric cardiology.

[18]  R. Kumar,et al.  Ivabradine in Post-operative Junctional Ectopic Tachycardia (JET): Breaking New Ground , 2019, Pediatric Cardiology.